Drug Discovery

#AI / data analytics / healthtech / informatics #Drug discovery #Technology

Oncology is a major focus for AI drug discovery companies

The application of artificial intelligence (AI) in the drug discovery process is promising to drastically cut down timelines and costs of bringing new therapies to patients. The potential for AI to address these pain points has drawn significant attention from investors and players in the pharmaceutical industry. … Read More

#Market Reports #News #Trends & Analysis

#Collaboration #Drug development #Drug discovery #Research

This week in drug discovery (11-15 October) 

News round-up by DDW’s Megan Thomas for 11-15 October   For this week’s drug discovery round up, DDW’s Megan Thomas has selected five stories that showcase how organisations and collaboration within the drug discovery industry can provide researchers and drug developers with the tools they need to move forward with… Read More

#News

#Biologics / Biotechnology #Cancer immunotherapy #Drug discovery #Flow Cytometry #Immuno-oncology #Webinar

Are you investigating pharmacological reactions?

Dr Nina Senutovitch, Senior Scientist, Sartorius, notes that more efficient and powerful tools are critical for furthering the development of highly target-specific immunotherapies, such as adoptive cell transfer therapies. These include Chimeric Antigen Receptor T cells (CAR-T), that harness an individual’s own immune system to attack cancerous cells. … Read More

#News

#AI / data analytics / healthtech / informatics #Biopharmaceutical #Drug discovery #Machine learning

The value of scientific intelligence in drug discovery

Leif Pedersen, President, Software, and David Lowis, Executive Director of Scientific Informatics at Certara, explain how scientific intelligence can refine and increase the effectiveness of critical decision points in drug discovery. Strong scientific intelligence capabilities are essential building blocks for a scientific informatics strategy and will increase the effectiveness of… Read More

#Exclusive Content #News

#AI #Covid-19 #Drug discovery #Pharmaceuticals

Understanding impact of pandemic-driven AI on drug discovery

In 18 months, vaccine research advanced AI in medicine by five to seven years. That’s cause for optimism — and investment — in the digital transformation of clinical development. Jeff Elton, CEO of ConcertAI, who has extensive experience in this sector, shares his insight with DDW. There… Read More

#Business & Investment #Covid-19 #Editor's Choice #Exclusive Content #News #Opinion

#Drug discovery #ELRIG #Events #Oncology

Gaining a career in drug discovery: Tips and tricks from the inside 

Sygnature Discovery will be presenting a workshop at ELRIG UK’s Drug Discovery 2021 event entitled, Gaining a career in industry: Learning tips and tricks from the inside. It will take place on the first day of Drug Discovery 2021 in Liverpool, from 10.50 – 11.50am in Room 11B. … Read More

#News

#Drug discovery #Nobel Prize

Could Nobel Prize 2021 findings lead to new drug discoveries? 

The 2021 Nobel Prize in Physiology or Medicine has been jointly awarded to David Julius and Ardem Patapoutian for their discoveries of receptors for temperature and touch. David Julius utilised capsaicin, a compound from chili peppers that induces a burning sensation, to identify a sensor in the nerve endings of the skin that responds… Read More

#News

#Drug discovery #iPSC #Stem cells #Therapeutics

Therapeutics research partnership to access induced Pluripotent Stem Cells 

Bone Therapeutics and Implant Therapeutics have signed a research evaluation agreement to enable Bone Therapeutics to access, evaluate and materially transfer Implant Therapeutics’ Induced Pluripotent Stem Cell (iPSC) lines, media, differentiation protocols and expertise.  Bone Therapeutics has developed a bone marrow-derived off-the-shelf, allogeneic MSC cell therapy platform. Read More

#News

#Antibodies #Covid-19 #Drug development #Drug discovery #Preclinical development #Therapeutics

Highlights of Carterra’s Bamlanivimab story

A recent sponsored DDW Sitting Down With podcast covered the bamlanivimab story and how this therapeutic went from lab to clinic in eight months during the pandemic. It is available to listen to here. Lu Rahman selects some of the highlights of this chat with Bryan Jones, Senior Research Fellow, BioTechnology Discovery Research, Eli… Read More

#Covid-19 #Exclusive Content #News

#Drug discovery #Drug innovation #ELRIG #Events #Innovation

ELRIG UK’s Drug Discovery 2021 

Given the unexpected couple of years we have had as a result of the Covid-19 pandemic, the drug discovery sector is no doubt looking forward to an in-person event at last. ELRIG UK’s Drug Discovery 2021 will take place at the ACC, Liverpool, UK on 19-20 October.  DDW has teamed up with ELRIG UK to produce… Read More

#Editor's Choice #News

#Antibodies #Bispecific therapeutics #Drug development #Drug discovery

Approaching bispecific antibody engineering

Dr Michael Fiebig, Chief Scientific Officer, Absolute Antibody offers insight for those starting with a new bispecific antibody project  who may feel a little daunted by the wealth of formats out there. Over the past 10-plus years, there has been a dramatic rise in the exploitation of bispecific antibodies with… Read More

#Business & Investment #Editor's Choice #Exclusive Content #News #Trends & Analysis